BRIEF published on 06/03/2024 at 17:05, 1 year 6 months ago KindlyMD Announces Closing of $6.8 Million Initial Public Offering Healthcare Nasdaq Initial Public Offering KindlyMD WallachBeth Capital
PRESS RELEASE published on 06/03/2024 at 17:00, 1 year 6 months ago KindlyMD Announces Closing of $6.8 Million Initial Public Offering KindlyMD, Inc. announces closing of IPO, offering 1,240,910 units at $5.50/unit, grossing $6.8M. Units consist of common stock, tradable warrants, and non-tradeable warrants Warrants Units IPO Common Stock KindlyMD Inc
BRIEF published on 05/31/2024 at 17:50, 1 year 6 months ago KindlyMD Announces Pricing of $6.8 Million Initial Public Offering Warrants Healthcare Nasdaq Initial Public Offering KindlyMD
PRESS RELEASE published on 05/31/2024 at 17:45, 1 year 6 months ago KindlyMD Announces Pricing of $6.8 Million Initial Public Offering KindlyMD, Inc. announces pricing of $6.8 million IPO consisting of 1,240,910 units with shares and warrants. Underwriters have an option to purchase additional securities. WallachBeth Capital LLC is the Sole Bookrunner Securities IPO Underwriters Pricing KindlyMD Inc.
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 35 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 40 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 50 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 21 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
